197 related articles for article (PubMed ID: 15481992)
21. Synthesis and anti-HIV activity of different novel nonclassical nucleosides.
Elgemeie GE; Mansour OA; Metwally NH
Nucleosides Nucleotides; 1999 Jan; 18(1):113-23. PubMed ID: 10048227
[TBL] [Abstract][Full Text] [Related]
22. Studies of anti-HIV transcription inhibitor quinolones: identification of potent N1-vinyl derivatives.
Tabarrini O; Massari S; Daelemans D; Meschini F; Manfroni G; Bottega L; Gatto B; Palumbo M; Pannecouque C; Cecchetti V
ChemMedChem; 2010 Nov; 5(11):1880-92. PubMed ID: 20928882
[TBL] [Abstract][Full Text] [Related]
23. Synthesis of novel MKC-442 analogues with potent activities against HIV-1.
El-Brollosy NR; Pedersen EB; Nielsen C
Arch Pharm (Weinheim); 2003 Jul; 336(4-5):236-41. PubMed ID: 12916058
[TBL] [Abstract][Full Text] [Related]
24. New HIV-1 replication inhibitors of the styryquinoline class bearing aroyl/acyl groups at the C-7 position: synthesis and biological activity.
Normand-Bayle M; Bénard C; Zouhiri F; Mouscadet JF; Leh H; Thomas CM; Mbemba G; Desmaële D; d'Angelo J
Bioorg Med Chem Lett; 2005 Sep; 15(18):4019-22. PubMed ID: 16002283
[TBL] [Abstract][Full Text] [Related]
25. Novel potential agents for human cytomegalovirus infection: synthesis and antiviral activity evaluation of benzothiadiazine dioxide acyclonucleosides.
Martinez A; Esteban AI; Castro A; Gil C; Conde S; Andrei G; Snoeck R; Balzarini J; De Clercq E
J Med Chem; 1999 Apr; 42(7):1145-50. PubMed ID: 10197958
[TBL] [Abstract][Full Text] [Related]
26. Nonnucleoside HIV-1 reverse transcriptase inhibitors; part 3. Synthesis and antiviral activity of 5-alkyl-2-[(aryl and alkyloxyl-carbonylmethyl)thio]-6-(1-naphthylmethyl) pyrimidin-4(3H)-ones.
He Y; Chen F; Yu X; Wang Y; De Clercq E; Balzarini J; Pannecouque C
Bioorg Chem; 2004 Dec; 32(6):536-48. PubMed ID: 15530994
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and anti-HIV activity of novel 3-substituted phenyl-6,7-dimethoxy-3a,4-dihydro-3H-indeno[1,2-c]isoxazole analogues.
Ali MA; Ismail R; Choon TS; Yoon YK; Wei AC; Pandian S; Samy JG; De Clercq E; Pannecouque C
Acta Pol Pharm; 2011; 68(3):343-8. PubMed ID: 21648188
[TBL] [Abstract][Full Text] [Related]
28. In-vitro anti-HIV and antitumor activity of new 3,6-disubstituted [1,2,4]triazolo[3,4-b][1,3,4]thiadiazoles and thiadiazine analogues.
Al-Soud YA; Al-Masoudi NA; Loddo R; La Colla P
Arch Pharm (Weinheim); 2008 Jun; 341(6):365-9. PubMed ID: 18493972
[TBL] [Abstract][Full Text] [Related]
29. Syntheses and anti-HIV activities of (+/-)-norcarbovir and (+/-)-norabacavir.
Huang W; Miller MJ; De Clercq E; Balzarini J
Org Biomol Chem; 2007 Apr; 5(8):1164-6. PubMed ID: 17406712
[TBL] [Abstract][Full Text] [Related]
30. Newer tetracycline derivatives: synthesis, anti-HIV, antimycobacterial activities and inhibition of HIV-1 integrase.
Sriram D; Yogeeswari P; Senchani G; Banerjee D
Bioorg Med Chem Lett; 2007 Apr; 17(8):2372-5. PubMed ID: 17376679
[TBL] [Abstract][Full Text] [Related]
31. Novel 1,2,3-thiadiazole derivatives as HIV-1 NNRTIs with improved potency: Synthesis and preliminary SAR studies.
Zhan P; Liu X; Li Z; Fang Z; Li Z; Wang D; Pannecouque C; Clercq ED
Bioorg Med Chem; 2009 Aug; 17(16):5920-7. PubMed ID: 19620009
[TBL] [Abstract][Full Text] [Related]
32. Antiretroviral activity of semisynthetic derivatives of glycopeptide antibiotics.
Balzarini J; Pannecouque C; De Clercq E; Pavlov AY; Printsevskaya SS; Miroshnikova OV; Reznikova MI; Preobrazhenskaya MN
J Med Chem; 2003 Jun; 46(13):2755-64. PubMed ID: 12801238
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and in vitro enzymatic and antiviral evaluation of phosphoramidate d4T derivatives as chain terminators.
Yang S; Pannecouque C; Lescrinier E; Giraut A; Herdewijn P
Org Biomol Chem; 2012 Jan; 10(1):146-53. PubMed ID: 22069085
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and evaluation of N-aryl pyrrolidinones as novel anti-HIV-1 agents. Part 1.
Wu B; Kuhen K; Ngoc Nguyen T; Ellis D; Anaclerio B; He X; Yang K; Karanewsky D; Yin H; Wolff K; Bieza K; Caldwell J; He Y
Bioorg Med Chem Lett; 2006 Jul; 16(13):3430-3. PubMed ID: 16632349
[TBL] [Abstract][Full Text] [Related]
35. Design, synthesis and biological evaluations of novel oxindoles as HIV-1 non-nucleoside reverse transcriptase inhibitors. Part I.
Jiang T; Kuhen KL; Wolff K; Yin H; Bieza K; Caldwell J; Bursulaya B; Wu TY; He Y
Bioorg Med Chem Lett; 2006 Apr; 16(8):2105-8. PubMed ID: 16480865
[TBL] [Abstract][Full Text] [Related]
36. Structure-function relationship of novel X4 HIV-1 entry inhibitors - L- and D-arginine peptide-aminoglycoside conjugates.
Hegde R; Borkow G; Berchanski A; Lapidot A
FEBS J; 2007 Dec; 274(24):6523-36. PubMed ID: 18028446
[TBL] [Abstract][Full Text] [Related]
37. Nitroimidazoles. V. Synthesis and anti-HIV evaluation of new 5-substituted piperazinyl-4-nitroimidazole derivatives.
Al-Soud YA; Al-Masoudi NA; Hassan HG; De Clercq E; Pannecouque C
Acta Pharm; 2007 Dec; 57(4):379-93. PubMed ID: 18165184
[TBL] [Abstract][Full Text] [Related]
38. 1,2,3-Thiadiazole thioacetanilides as a novel class of potent HIV-1 non-nucleoside reverse transcriptase inhibitors.
Zhan P; Liu X; Cao Y; Wang Y; Pannecouque C; De Clercq E
Bioorg Med Chem Lett; 2008 Oct; 18(20):5368-71. PubMed ID: 18824350
[TBL] [Abstract][Full Text] [Related]
39. Structure and anti-HIV activity of micrandilactones B and C, new nortriterpenoids possessing a unique skeleton from Schisandra micrantha.
Li RT; Han QB; Zheng YT; Wang RR; Yang LM; Lu Y; Sang SQ; Zheng QT; Zhao QS; Sun HD
Chem Commun (Camb); 2005 Jun; (23):2936-8. PubMed ID: 15957031
[TBL] [Abstract][Full Text] [Related]
40. Nevirapine derivatives with broad-spectrum chemotherapeutic properties for the effective treatment of HIV/AIDS.
Sriram D; Srichakravarthy N; Bal TR; Yogeeswari P
Biomed Pharmacother; 2005 Sep; 59(8):456-9. PubMed ID: 16140495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]